
pmid: 2057656
AbstractChanneling is a form of allocation bias, where drugs with similar therapeutic indications are prescribed to groups of patients with prognostic differences. Claimed advantages of a new drug may channel it to patients with special pre‐existing morbidity, with the consequence that disease states can be incorrectly attributed to use of the drug. For the study of adverse drug reactions, large databases supply information on comedication and morbidity of patients. For diseases with a stepped‐are approach, the drug history of patients, as available from some databases, can show channeling of drugs to patients with markers of relatively severe disease.
Bias, Drug Therapy, Drug-Related Side Effects and Adverse Reactions, Clinical Pharmacy Information Systems, Research Design, Humans, Asthma, Drug Utilization, Demography
Bias, Drug Therapy, Drug-Related Side Effects and Adverse Reactions, Clinical Pharmacy Information Systems, Research Design, Humans, Asthma, Drug Utilization, Demography
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 219 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
